Biora Therapeutnew 001 Stock Current Valuation
| 4ZU0 Stock | 5.10 0.00 0.00% |
Valuation analysis of BIORA THERAPEUTNEW 001 helps investors to measure BIORA THERAPEUTNEW's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that BIORA THERAPEUTNEW's price fluctuation is out of control at this time. Calculation of the real value of BIORA THERAPEUTNEW 001 is based on 3 months time horizon. Increasing BIORA THERAPEUTNEW's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BIORA stock is determined by what a typical buyer is willing to pay for full or partial control of BIORA THERAPEUTNEW 001. Since BIORA THERAPEUTNEW is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BIORA Stock. However, BIORA THERAPEUTNEW's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.1 | Real 6.02 | Hype 5.1 |
The real value of BIORA Stock, also known as its intrinsic value, is the underlying worth of BIORA THERAPEUTNEW 001 Company, which is reflected in its stock price. It is based on BIORA THERAPEUTNEW's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BIORA THERAPEUTNEW's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BIORA THERAPEUTNEW 001 helps investors to forecast how BIORA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BIORA THERAPEUTNEW more accurately as focusing exclusively on BIORA THERAPEUTNEW's fundamentals will not take into account other important factors: BIORA THERAPEUTNEW 001 Company Current Valuation Analysis
BIORA THERAPEUTNEW's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, BIORA THERAPEUTNEW 001 has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current valuation for all Germany stocks is 100.0% higher than that of the company.
BIORA Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIORA THERAPEUTNEW's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIORA THERAPEUTNEW could also be used in its relative valuation, which is a method of valuing BIORA THERAPEUTNEW by comparing valuation metrics of similar companies.BIORA THERAPEUTNEW is currently under evaluation in current valuation category among its peers.
About BIORA THERAPEUTNEW Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIORA THERAPEUTNEW 001's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIORA THERAPEUTNEW using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIORA THERAPEUTNEW 001 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in BIORA Stock
BIORA THERAPEUTNEW financial ratios help investors to determine whether BIORA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIORA with respect to the benefits of owning BIORA THERAPEUTNEW security.